The government is exploring terms by which the UK could still be part of EMA after its departure from the EU, Theresa May said in a key speech on Brexit. / read more /
JLL, a real estate and investment management firm, recently released a new report on three trends shaping labs for the future of life sciences R&D. / read more /
Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology. / read more /
CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them. / read more /
Participate in BioPlan's 15th Annual Global Biopharmaceutical Manufacturing Study. Share your insight on current global and regional trends affecting biomanufacturing and BioPlan will donate $15 (up to $2,000) on your behalf to global health charities. Participants also receive a free aggregated summary of this year's results and an updated 15 Top Trends in Biopharmaceutical Manufacturing White Paper.
Vaccines—from childhood and influenza immunizations, to epidemic prevention, to cancer and therapeutic treatments—present unique development challenges. In this Vaccine and Manufacturing eBook, the editors explore development and manufacturing options to make vaccines more accessible.
